High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

We show that elevated levels of circulating suPAR in patients with resectable pancreatic adenocarcinoma are associated with a significantly impaired overall sur

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Loosen, Sven (VerfasserIn) , Bergmann, Frank (VerfasserIn) , Longerich, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08 February 2019
In: Carcinogenesis
Year: 2019, Jahrgang: 40, Heft: 8, Pages: 947-955
ISSN:1460-2180
DOI:10.1093/carcin/bgz033
Online-Zugang:Verlag, Volltext: https://doi.org/10.1093/carcin/bgz033
Verlag, Volltext: https://academic.oup.com/carcin/article/40/8/947/5364809
Volltext
Verfasserangaben:Sven H. Loosen, Frank Tacke, Niklas Püthe, Marcel Binneboesel, Georg Wiltberger, Patrick H. Alizai, Jakob N. Kather, Pia Paffenholz, Thomas Ritz, Alexander Koch, Frank Bergmann, Christian Trautwein, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann, Tom Luedde

MARC

LEADER 00000caa a2200000 c 4500
001 1684400848
003 DE-627
005 20220817174751.0
007 cr uuu---uuuuu
008 191205s2019 xx |||||o 00| ||eng c
024 7 |a 10.1093/carcin/bgz033  |2 doi 
035 |a (DE-627)1684400848 
035 |a (DE-599)KXP1684400848 
035 |a (OCoLC)1341280375 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Loosen, Sven  |d 1988-  |e VerfasserIn  |0 (DE-588)1065070721  |0 (DE-627)815579810  |0 (DE-576)424757524  |4 aut 
245 1 0 |a High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma  |c Sven H. Loosen, Frank Tacke, Niklas Püthe, Marcel Binneboesel, Georg Wiltberger, Patrick H. Alizai, Jakob N. Kather, Pia Paffenholz, Thomas Ritz, Alexander Koch, Frank Bergmann, Christian Trautwein, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann, Tom Luedde 
264 1 |c 08 February 2019 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.12.2019 
520 |a We show that elevated levels of circulating suPAR in patients with resectable pancreatic adenocarcinoma are associated with a significantly impaired overall sur 
700 1 |a Bergmann, Frank  |d 1972-  |e VerfasserIn  |0 (DE-588)124407900  |0 (DE-627)363326081  |0 (DE-576)294157840  |4 aut 
700 1 |a Longerich, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)128494514  |0 (DE-627)373916124  |0 (DE-576)297178059  |4 aut 
773 0 8 |i Enthalten in  |t Carcinogenesis  |d Oxford : Oxford Univ. Press, 1980  |g 40(2019), 8, Seite 947-955  |h Online-Ressource  |w (DE-627)269243445  |w (DE-600)1474206-8  |w (DE-576)090854381  |x 1460-2180  |7 nnas  |a High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma 
773 1 8 |g volume:40  |g year:2019  |g number:8  |g pages:947-955  |g extent:9  |a High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma 
856 4 0 |u https://doi.org/10.1093/carcin/bgz033  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/carcin/article/40/8/947/5364809  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20191205 
993 |a Article 
994 |a 2019 
998 |g 128494514  |a Longerich, Thomas  |m 128494514:Longerich, Thomas  |d 910000  |d 912000  |e 910000PL128494514  |e 912000PL128494514  |k 0/910000/  |k 1/910000/912000/  |p 13 
998 |g 124407900  |a Bergmann, Frank  |m 124407900:Bergmann, Frank  |d 910000  |d 912000  |d 50000  |e 910000PB124407900  |e 912000PB124407900  |e 50000PB124407900  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 11 
999 |a KXP-PPN1684400848  |e 3556993120 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma","title_sort":"High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma"}],"person":[{"given":"Sven","family":"Loosen","role":"aut","roleDisplay":"VerfasserIn","display":"Loosen, Sven"},{"given":"Frank","family":"Bergmann","role":"aut","roleDisplay":"VerfasserIn","display":"Bergmann, Frank"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Longerich, Thomas","given":"Thomas","family":"Longerich"}],"recId":"1684400848","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.12.2019"],"id":{"doi":["10.1093/carcin/bgz033"],"eki":["1684400848"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"08 February 2019"}],"name":{"displayForm":["Sven H. Loosen, Frank Tacke, Niklas Püthe, Marcel Binneboesel, Georg Wiltberger, Patrick H. Alizai, Jakob N. Kather, Pia Paffenholz, Thomas Ritz, Alexander Koch, Frank Bergmann, Christian Trautwein, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann, Tom Luedde"]},"relHost":[{"language":["eng"],"recId":"269243445","disp":"High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinomaCarcinogenesis","note":["Gesehen am 05.01.2017"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"9","volume":"40","text":"40(2019), 8, Seite 947-955","pages":"947-955","issue":"8","year":"2019"},"titleAlt":[{"title":"Carcinogenesis online"}],"pubHistory":["1.1980 -"],"title":[{"title":"Carcinogenesis","title_sort":"Carcinogenesis"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1460-2180"],"eki":["269243445"],"zdb":["1474206-8"]},"origin":[{"publisherPlace":"Oxford","publisher":"Oxford Univ. Press","dateIssuedKey":"1980","dateIssuedDisp":"1980-"}]}],"physDesc":[{"extent":"9 S."}]} 
SRT |a LOOSENSVENHIGHBASELI0820